Health Care Service Corporation, a Blue Cross and Blue Shield licensee across five states, co-led the round for Solera Health ...
Zacks.com on MSN6d
PacBio Stock May Gain Following the Collaborated Launch of GutIDWith PacBio's well-known sequencing accuracy and Intus Bio's patented strain-level resolution assay and AI-powered analysis, ...
PacBio (NASDAQ: PACB), developer of the world’s most advanced sequencing technologies, and Intus Bio, a leader in microbiome research and discovery, today unveiled GutID, the first commercial human ...
PacBio (PACB) and Intus Bio unveiled GutID, the first commercial human gut health test powered by Intus Bio’s groundbreaking Titan-1 platform ...
“We are proud to partner with PacBio for their first human health-related commercial application,” said Paul Denslow, CEO of Intus Bio. “High accuracy, long-read sequencing is essential to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback